secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2026-09-17T11:18:22+00:00
Accession:  0001104659-26-108417
Event type: dividend
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior declares $8.13/shr special dividend contingent on Supernus merger closing
--------------------------------------------------------------------------------

- Special dividend of $8.13 per share; record date October 30, 2026; payment expected ~November 6, 2026.
- Payment contingent on merger closing expected on or about November 2, 2026; no dividend if merger fails.
- Supernus stockholders ineligible for dividend on Indivior shares received in merger.
- Indivior expects majority of dividend to exceed current/accumulated earnings; treated as return of capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/0001104659-26-108417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000110465926108417/tm2623753d7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-108417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer